CompletedPhase 1ketamine

Spreading Depolarization and Ketamine Suppression

Sponsored by University of New Mexico

NCT ID
NCT02501941
Target Enrollment
10 participants
Start Date
2015-07
Est. Completion
2017-05-01

About This Study

Hypothesis: Cortical spreading depolarizations are inhibited by the NMDA receptor antagonist Ketamine Aim 1: To demonstrate, in a group of patients with acute severe brain injury requiring surgery including traumatic brain injury and aneurysmal subarachnoid hemorrhage, whether use of continuous infusion of ketamine decreases frequency of occurrence of cortical spreading depolarizations.

Conditions Studied

Cortical Spreading DepolarizationCortical Spreading DepressionSubarachoid HemorrhageTraumatic Brain Injury

Interventions

  • ketamine

Eligibility

Age:18 Years - 90 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* GCS \<8
* SAH or severe traumatic brain injury requiring craniotomy
* Consent obtainable (via legal representative)
* Ictus (bleed or injury) within 48 hours of enrollment
* Clinically appropriate for multimodality monitoring

Exclusion Criteria:

* Anticipated survival \<48 hours
* No craniotomy
* Infratentorial craniotomy only•Unable to obtain consent
* Absence of clinically used multimodality monitoring
* Prisoners
* Pregnant

Study Locations (1)

University of New Mexico
Albuquerque, New Mexico, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source